Follow The Filings

MPT Medical Properties Trust Inc.

Real Estate, filed as MEDICAL PPTYS TRUST INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.0%
  • $21M

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Philippe Laffont, Coatue Management). Not free-float ownership.

  1. Philippe Laffont 0.04%

Who owns MPT

Sorted by value, long equity only, as of 2026 Q2.

History
Philippe Laffont, Coatue Management 0.04% Hold 4,525,398 $21M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by MPT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MPT insider trades
  • $9,545 bought by 1 insider
  • $306K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. James Kevin Hanna Senior VP, Controller & CAO
    Buy
    $9,545 2,300 shares at $4.15 +0.4% to stake
    Traded Aug 20 Filed Aug 20
    ↗
  2. Rosa Handley Hooper SVP of Operations
    Sale
    $10K 2,000 shares at $5.00 0.5% of stake
    Traded Dec 15, 2025 Filed Dec 16, 2025
    ↗
  3. Michael G Stewart Director
    Sale
    $296K 59,000 shares at $5.02 27% of stake
    Traded Nov 19, 2025 Filed Nov 21, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 24 share withholdings for taxes, 19 stock grants, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $871.8M $995.55M $972.02M
Gross profit * $761.73M $921.38M $881.72M
Gross margin * 87.4% 92.6% 90.7%
Net income -$0.556B -$2.41B -$0.277B
Net margin * -63.8% -242.1% -28.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $18.3B $14.29B $15B
Total equity $7.63B $4.83B $4.61B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $505.79M $245.48M $230.77M
Cash from investing $0.518B $1.32B -$0.265B
Cash from financing -$1.02B -$1.48B $0.228B
Net change in cash * $3.02M $84.44M $194.11M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.